GLOPID-R

21/02/1818

National Institute of Health Carlos IIIRearbovir: a network of researchers for antivirals against arboviral diseases

GloPID-R member National Institute of Health Carlos III, with Tomás López-Peña as representative, shared with the members a newly created consortium Rearbovir. A network of seven research groups with different and complementary expertise recently set up Rearbovir in Spain through the financial support of the Ministry of Economy, Industry and Competitiveness (SAF2016-81856-REDT) to join efforts against arboviral diseases, which constitute a growing and dangerous group of global infectious diseases.

The purpose of this network is to exchange knowledge and expertise among researchers working on medicinal chemistry, molecular modelling, molecular biology and virology, animal and vector models, as well as clinical laboratory diagnosis and surveillance with the common objective to advance in the development of antiviral drugs against these arboviral diseases.

The recently launched website shares latest activities, news, and publications. In the future, the network intends to open the network to other research groups and to participate in larger initiatives at the international level.

EU Flag

The GloPID-R Secretariat is a project which receives funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 874667.